Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Objective: To compare the therapeutic effects of vitamin D 3 plus fluoxetine and fluoxetine alone in patients with major depressive disorder. Methods: In the present double-blind, randomized, placebo-controlled trial, 42 patients with a diagnosis of major depressive disorder based on DSM-IV criteria were randomly assigned into two groups to receive daily either 1500 IU vitamin D 3 plus 20 mg fluoxetine or fluoxetine alone for 8 weeks. Depression severity was assessed at 2-week intervals using the 24-item Hamilton Depression Rating Scale (HDRS) as a primary outcome measure and the 21-item Beck Depression Inventory (BDI) as a secondary outcome measure. Serum 25(OH) vitamin D was measured at baseline and after intervention. Results: Forty patients completed the trial. A two-way repeated-measures analysis of variance showed that depression severity based on HDRS and BDI decreased significantly after intervention, with a significant difference between the two groups. The vitamin D + fluoxetine combination was significantly better than fluoxetine alone from the fourth week of treatment. Conclusions: In the present 8-week trial, the vitamin D + fluoxetine combination was superior to fluoxetine alone in controlling depressive symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Holick, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra070553 · Cited by 13,720
DEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION
Fava, M., & Davidson, K. G. (1996) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70283-5 · Cited by 797
Bone Mineral Density in Women with Depression
Michelson, D., Stratakis, C., Hill, L., Reynolds, J., Galliven, E., Chrousos, G., & Gold, P. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351602 · Cited by 471
Jorde, R., Sneve, M., Figenschau, Y., Svartberg, J., & Waterloo, K. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02008.x · Cited by 433 · cited 3×
“…studies have shown that there is an inverse association between vitamin D status and depressive symptoms (Armstrong et al., 2007; Hoogendijk et al., 2008; Jorde et al., 2008; Nanri et al., 2009; Oren et al., 1994; Schneider et al., 2000; Stewart and Hirani, 2010; Wilkins et al., 2006).”
BackgroundResultArroll, B. (2005) · The Annals of Family Medicine · doi:10.1370/afm.349 · Cited by 351 · cited 1×
“It is reported that about 19–34% of major depressive disorder cases resist good response to routine antidepressants (Arroll et al., 2005; Fava and Davidson, 1996).”
BackgroundLow Bone Mass in Premenopausal Women With Depression
Eskandari, F. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.21.2329 · Cited by 157
Annual high-dose vitamin D3and mental well-being: randomised controlled trial
Sanders, K. M., Stuart, A. L., Williamson, E. J., Jacka, F. N., Dodd, S., Nicholson, G., & Berk, M. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.087544 · Cited by 145 · cited 1×
“However, a large randomized trial in older women has shown that a single annual dose of 500,000 IU of vitamin D3 for 3–5 years had no benefit on mood, although there was a non-significant improvement in those taking medications for anxiety and depression (Sanders et al., 2011).”
BackgroundVitamin D supplements in geriatric major depression
Zanetidou, S., Murri, M. B., Buffa, A., Malavolta, N., Anzivino, F., & Bertakis, K. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2703 · Cited by 38
Cited by
Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses
Sarris, J., Murphy, J., Mischoulon, D., Papakostas, G. I., Fava, M., Berk, M., & Ng, C. H. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15091228 · Cited by 436
Spedding, S. (2014) · Nutrients · doi:10.3390/nu6041501 · Cited by 290
Parker, G. B., Brotchie, H., & Graham, R. K. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.08.082 · Cited by 288
Vitamin D as a neurosteroid affecting the developing and adult brain
Groves, N. J., McGrath, J. J., & Burne, T. H. J. (2014) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071813-105557 · Cited by 256
Gowda, U., Mutowo, M. P., Smith, B. J., Wluka, A. E., & Renzaho, A. M. N. (2015) · Nutrition · doi:10.1016/j.nut.2014.06.017 · Cited by 229
“Blinding of participants and research personnel was either high or unclear in five studies [12,28–31].”
BackgroundMethodResultInfluential
Metadata
- Authors
- Khoraminya, N., Tehrani-Doost, M., Jazayeri, S., Hosseini, A., & Djazayery, A.
- Venue
- Australian & New Zealand Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2012-10-23
- Volume
- 47
- Issue
- 3
- Pages
- 271-275
- ISSN
- 0004-8674 (ISSN-L)
- 1440-1614
- OpenAlex
- W1981262591
- Cited by
- 145
- References
- 8
- FWCI
- 6.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder. https://app.cochat.ai/papers/10.1177/0004867412465022
- The paper
- Khoraminya, N., Tehrani-Doost, M., Jazayeri, S., Hosseini, A., & Djazayery, A. (2013). Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1177/0004867412465022
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.